A Multi-centre Prospective, Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a Real World Population With Type 2 Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 04 Jul 2019
Price : $35 *
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 28 Aug 2018 Status changed from active, no longer recruiting to completed.
- 12 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 27 Dec 2017 New trial record